BackSanten Pharmaceutical , Ltd. Overview

Santen Pharmaceutical , Ltd. Receivables

Latest receivables for SNPHF: $63B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$63.15B
↓ 6.31% YoYΔ $-4.25B vs prior year quarter

Peer trimmed avg / median

Loading

Santen Pharmaceutical , Ltd. Receivables History

Loading

Santen Pharmaceutical , Ltd. vs. peers: Receivables Comparison

Loading

Santen Pharmaceutical , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Santen Pharmaceutical , Ltd. (SNPHF) FAQ

Santen Pharmaceutical , Ltd. (SNPHF) currently reports a receivables of $63B as of June 2026. That compares with $67B in the prior-year period — down 6.3% year over year. Use the charts on this page to explore Santen Pharmaceutical , Ltd.'s receivables history and peer comparisons.

Santen Pharmaceutical , Ltd.'s receivables decreased from $67B to $63B — a 6.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Santen Pharmaceutical , Ltd. reported $63B in receivables as of June 2026. That compares with $67B in the prior-year period — down 6.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $63B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Santen Pharmaceutical , Ltd., and consider following SNPHF for alerts when major investors trade the stock.